UNSPSC 51373421: Chlorpheniramine/hydrocodone/nh4/phenindamine/phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373421 Chlorpheniramine/hydrocodone/nh4/phenindamine/phenylephrine/pyrilamine is a Commodity code under which state and local governments procure generic multi-source pharmaceutical and over-the-counter products, including combination cold and allergy medications, for distribution through community health systems, emergency-response programs, and cooperative purchasing networks. Recent solicitations show state and local buyers acquiring finished pharmaceutical products with specific National Drug Codes (NDCs) through competitive bidding and cooperative purchasing agreements, often bundled with related OTC products and requiring vendors to supply through authorized pharmaceutical wholesalers. Issuing bodies include county health departments, state cooperative purchasing alliances serving multiple jurisdictions, and participating local government facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, represents a significant buyer under this code, aggregating demand across participating state and local members.

Activity under the code spans at least Florida and Minnesota, with MMCAP's cooperative vehicle extending reach to Oregon and other participating jurisdictions. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, with the final response deadline July 26, 2023 (response deadline appears inconsistent with posting date; per the source, responses were due July 26, 2023). The Minnesota Department of Administration's Office of State Procurement, on behalf of MMCAP, issued RFP S1070000015802 on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, with a response deadline of March 26, 2026. MMCAP's RFP requires vendors to supply through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and to certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), with awarded contracts effective July 1, 2026.